| #31 |
Raj Bandekar |
Honeywell |
1 |
| #31 |
Anton Paul Ness |
Whitaker & |
1 |
| #31 |
Daniel Martin |
Nectar Services |
1 |
| #31 |
Donald A. Lawson |
Medi-Dose |
1 |
| #31 |
Boyoung Kim |
Merck |
1 |
| #31 |
Rebecca Nofsinger |
Merck |
1 |
| #31 |
Albert L. Chase |
— |
1 |
| #31 |
Hong Ye |
Johnson & Johnson |
1 |
| #31 |
Mark Douglas Petro-Roy |
Marine Acquisition (Us) Incorporated |
1 |
| #31 |
Kelly JORDAN-SCIUTTO |
University of Pennsylvania |
1 |
| #31 |
Russell T. Kronengold |
Kensey Nash Bvf Technology |
1 |
| #31 |
Stephen E. McIlhenny |
Orthovita |
1 |
| #31 |
Alain P. Steven |
Viridity Energy |
1 |
| #31 |
Hong-Xin Li |
Pq |
1 |
| #31 |
Daniel V. Paone |
Merck |
1 |
| #31 |
Eric Tryson |
Rb Distribution |
1 |
| #31 |
W. Mark Eickhoff |
Nano Systems L.L.C. |
1 |
| #31 |
Leonardo R. Allain |
Merck |
1 |
| #31 |
Christopher Ton |
Mesoblast International Sàrl |
1 |
| #31 |
Charles F. Niesley |
Arris Enterprises |
1 |
| #31 |
Jose Antonio Trejo-O'Reilly |
— |
1 |
| #31 |
Rasappa Arumugham |
Pfizer |
1 |
| #31 |
Dennis G. Grubb |
Aquablok |
1 |
| #31 |
Daniel Choo |
University of Pennsylvania |
1 |
| #31 |
Sachin Lohani |
Merck |
1 |
| #31 |
Bolatito Ajayi |
Dow Global Technologies |
1 |
| #31 |
Micael Guillot |
Aprecia Pharmaceuticals |
1 |
| #31 |
David M. Gargani |
General Instrument |
1 |